A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

NCT00475072 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

14

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C, Chronic

Interventions

DRUG: peginterferon alfa-2a [Pegasys]
DRUG: ribavirin

Sponsor

Hoffmann-La Roche